Canaccord Genuity Maintains Buy on Artivion, Lowers Price Target to $30
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $40 to $30.
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $40 to $30.